Navigation Links
Gum disease may be caused by blood clotting gene

Researchers at the State University of New York at the Buffalo School of Dental Medicine have found out that variation in the gene for fibrinogen, a protein useful in blood clotting may increase the risk of severe gum disease. Compared to people with healthy gums, those with gum disease carry certain gene variations linked to high levels of fibrinogen, according to the study.

79 people with gum disease and a "control" group of 75 people with healthy gums were screened for two variations of fibrinogen genes that increase levels// of the protein. Fifty-one percent of people with gum disease had one or both gene variations, compared with 30% of the control group.

The findings, which were presented at the annual meeting of the American Association for Dental Research, show that the risk of developing severe gum disease rose from two to six times in people with the gene variation when compared to the normal population.

High levels of fibrinogen are known to increase the risk of heart disease by making it easier for blood clots to form. High levels of the protein can increase inflammation, and perhaps the risk of gum disease, in several ways, according to the researchers.

Not only does the protein provide the structure to which inflammatory cells attach, but it also affects immune responses. In addition, fibrinogen facilitates the growth and invasion of bacteria.

The study concludes its findings by advising the people with this gene variation to be more careful with their dental hygiene and to visit the dentist more often.


'"/>




Page: 1

Related medicine news :

1. Evidence Links Protein Damage to Neurodegenerative diseases like Parkinsons and Alzheimers
2. Fight Heart disease and Pain with Meditation
3. Heart disease in the newborn is related to maternal malnutrition
4. Starvation in pregnant women can cause heart disease to their children
5. Individuals with sleep related breathing disorders more prone to heart disease
6. And now they say infections can cause heart disease!!!!
7. And now they say infections can cause heart disease!!!!
8. India takes on foot-and-mouth disease by vaccinating animals
9. Ticks may cause more diseases
10. Asthma! A new warning for heart disease
11. Heart disease threat starts early in life for Diabetics
Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Gum disease may caused blood clotting gene

(Date:9/4/2008)... may be shortchanging their golden years by tappin...iversity of Illinois expert who has studied the fe..., More than three of every four Americans trim th...iming benefits early, a choice many might forego i... consequences, law professor Richard L. Kaplan say...
(Date:9/4/2008)...ncology contract research organization, has publis...uanced Approach to Get Into the Clinic Faster.&quo...al research scientist with 35 years of experience,...mmonly viewed as straightforward investigations ru...rue integration with preclinical, regulatory and c...
(Date:9/4/2008)...NORWICH, England and ONGAR, Ireland,Sept. 4 /PRNe...ofield Media,Europe Ltd, announced on the 29th Aug... publication from Silverdog Publishing., Health a... the iconic,Health and Safety at Work Act 1974 and.... It has been relied upon by blue-chip corporates,...
(Date:9/4/2008)...-FirstCall/ -- ULURU Inc. (Amex:,ULU) today announ...Weisel,Partners Healthcare Conference at 3:15 p.m....out ULURU Inc.:, ULURU Inc. is an emerging specia...ent of a portfolio of wound management, plastic su...nd consumers improved clinical,outcomes through co...
Breaking Medicine News(10 mins):Health News:New guide explores making the most of Social Security 2Health News:New guide explores making the most of Social Security 3Health News:Oncology Clinical Research Scientist Recommends a Nuanced Preclinical Study Process to Speed Drug Development 2Health News:Oncology Clinical Research Scientist Recommends a Nuanced Preclinical Study Process to Speed Drug Development 3Health News:Schofield Publishing Enters the Newsletter Market 2
...alian Government has announced that it will be spe...ird flu drug Relenza from Biota Holdings. //Austra...er yesterday. The drug had been licensed by Biota...e, but Biota had alleged that GSK failed to market...
...ddenly collapsed on a family in Karawal Nagar area...e children and two adults and injuring four others...ng beside the wall of a school building, which had...eting deputy commissioner of police R.L Meena said...
... Suk the cloning pioneer of South Korea is defendi... upon the editors of Science magazine in Washingto... US scientific magazine, Donald Kennedy said that ...ertainly not ... months' to explain and support hi...
...puncture, Ayurveda, Chinese movement therapies suc...ng are just some of the commonly used alternative ... over Europe. //Perhaps, this is because it’s stro...e conventional medical treatment for cancer with t...
Other Medicine News:Health News:Scientist Calls Upon Media To Retract His Work 2
(Date:9/3/2008)...ollow up results from chronically infected Hepatit... data obtained earlier in 2008, - Study is the f...term antiviral effect of therapeutic Hepati...gly support move into a second generation, vaccin...ing through TLR acti...
(Date:9/3/2008)...Company to Discuss Phase 3 Plans with FDA, PRINCE...ics, Inc.,announced today that it successfully co... of the company,s new, innovative low-dose, once-w...rs to by its internal product,code AG-200-15. The ...t its,primary endpoint of ovulation suppression, c...
(Date:9/2/2008)...t. 3 /- Forest Laboratories...A. today announced results from,two global Phase I...ing,inhaled anticholinergic for the treatment of p... (COPD). In both the ACCLAIM/COPD I&II,(AClidinium...oderate to,Severe COPD Patients) studies, once-dai...
(Date:9/2/2008)...Meets Primary Bone Mineral Density and Secondary E...Company to Host Conference Call and Webcast Wednes...am ET / 5:30 am PT, SAN DIEGO, Sept. 2 /PRNewswir...aq: NBIX ) today announced positive safety and ef...ial using its proprietary, orally-active,nonpeptid...
Breaking Medicine Technology:Favourable Six Months Follow-Up Results From Intercell's Phase II Therapeutic Hepatitis C Program 2Favourable Six Months Follow-Up Results From Intercell's Phase II Therapeutic Hepatitis C Program 3Favourable Six Months Follow-Up Results From Intercell's Phase II Therapeutic Hepatitis C Program 4Agile Therapeutics Achieves Phase 2 Study Endpoints in Key Clinical Trials with New, Innovative Low-Dose Contraceptive Patch 2Agile Therapeutics Achieves Phase 2 Study Endpoints in Key Clinical Trials with New, Innovative Low-Dose Contraceptive Patch 3Agile Therapeutics Achieves Phase 2 Study Endpoints in Key Clinical Trials with New, Innovative Low-Dose Contraceptive Patch 4Phase III Clinical Studies of Aclidinium Bromide Show Statistical Significance vs. Placebo in Patients With Chronic Obstructive Pulmonary Disease (COPD) 2Phase III Clinical Studies of Aclidinium Bromide Show Statistical Significance vs. Placebo in Patients With Chronic Obstructive Pulmonary Disease (COPD) 3Phase III Clinical Studies of Aclidinium Bromide Show Statistical Significance vs. Placebo in Patients With Chronic Obstructive Pulmonary Disease (COPD) 4Phase III Clinical Studies of Aclidinium Bromide Show Statistical Significance vs. Placebo in Patients With Chronic Obstructive Pulmonary Disease (COPD) 5Phase III Clinical Studies of Aclidinium Bromide Show Statistical Significance vs. Placebo in Patients With Chronic Obstructive Pulmonary Disease (COPD) 6Neurocrine Biosciences Announces Successful Elagolix PETAL Study in Endometriosis 2Neurocrine Biosciences Announces Successful Elagolix PETAL Study in Endometriosis 3Neurocrine Biosciences Announces Successful Elagolix PETAL Study in Endometriosis 4Neurocrine Biosciences Announces Successful Elagolix PETAL Study in Endometriosis 5Neurocrine Biosciences Announces Successful Elagolix PETAL Study in Endometriosis 6A tricky tumor virus 9695 1A tricky tumor virus 9695 2Just hours apart 2 brothers undergo robotic prostate cancer surgery 9693 1Just hours apart 2 brothers undergo robotic prostate cancer surgery 9693 2Relatives who decline organ donations face conflict and guilt 9691 1Relatives who decline organ donations face conflict and guilt 9691 2Relatives who decline organ donations face conflict and guilt 9691 3New gene test for prostate cancer at hand 9689 1New gene test for prostate cancer at hand 9689 2
.../PRNewswire-FirstCall/ --,Nuvelo, Inc. today annou... (R-Spondin1), a secreted protein currently in pre...ecific and potent,stimulator of gastrointestinal (...maged in patients with inflammatory bowel,conditio...is. The,study, entitled "R-Spondin1, A Novel Intes...
...abetes Insulin-Free, WASHINGTON, April 10, 2007 /P... adult stem cell therapy, the Journal of the,Ameri...udy in which,14 of 15 Juvenile Diabetes patients d... an adult stem cell treatment. According,to U.S. R...cant in,that it,s the first attempt at using stem ...
Other Medicine Technology:Nuvelo Announces Publication of NU206 Study Results in,Gastroenterology 2Nuvelo Announces Publication of NU206 Study Results in,Gastroenterology 3Nuvelo Announces Publication of NU206 Study Results in,Gastroenterology 4Newest Adult Stem Therapy Treats Diabetes 2
...tory and a worldwide leader in innovative laborato...ive test menu of highly complex and unique medical...y the University of Utah, ARUP Laboratories' clien...ty teaching hospitals and children's hospitals, ma...
...tory and a worldwide leader in innovative laborato...ive test menu of highly complex and unique medical...y the University of Utah, ARUP Laboratories' clien...ty teaching hospitals and children's hospitals, ma...
...tory and a worldwide leader in innovative laborato...ive test menu of highly complex and unique medical...y the University of Utah, ARUP Laboratories' clien...ty teaching hospitals and children's hospitals, ma...
...tory and a worldwide leader in innovative laborato...ive test menu of highly complex and unique medical...y the University of Utah, ARUP Laboratories' clien...ty teaching hospitals and children's hospitals, ma...
Medicine Products: